NO951751D0 - Molekylmerking ved bruk av 2-hydraminopyridin-derivater - Google Patents

Molekylmerking ved bruk av 2-hydraminopyridin-derivater

Info

Publication number
NO951751D0
NO951751D0 NO951751A NO951751A NO951751D0 NO 951751 D0 NO951751 D0 NO 951751D0 NO 951751 A NO951751 A NO 951751A NO 951751 A NO951751 A NO 951751A NO 951751 D0 NO951751 D0 NO 951751D0
Authority
NO
Norway
Prior art keywords
pct
compound
hydraminopyridine
derivatives
date
Prior art date
Application number
NO951751A
Other languages
English (en)
Other versions
NO951751L (no
NO305364B1 (no
Inventor
Michael Jeffrey Abrams
Gary James Bridger
David Aaron Schwartz
Sreenivasan Padmanabhan
Michael Evert Ultee
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of NO951751D0 publication Critical patent/NO951751D0/no
Publication of NO951751L publication Critical patent/NO951751L/no
Publication of NO305364B1 publication Critical patent/NO305364B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
NO951751A 1992-11-05 1995-05-04 2-hydraminopyridin-derivater, konjugater inneholdende disse og merkete makro molekyler NO305364B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223168A GB9223168D0 (en) 1992-11-05 1992-11-05 Improvements in molecule labelling
PCT/GB1993/002259 WO1994010149A1 (en) 1992-11-05 1993-11-03 Molecule labelling using 2-hydraninopyridine derivatives

Publications (3)

Publication Number Publication Date
NO951751D0 true NO951751D0 (no) 1995-05-04
NO951751L NO951751L (no) 1995-06-12
NO305364B1 NO305364B1 (no) 1999-05-18

Family

ID=10724568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951751A NO305364B1 (no) 1992-11-05 1995-05-04 2-hydraminopyridin-derivater, konjugater inneholdende disse og merkete makro molekyler

Country Status (19)

Country Link
US (1) US5679778A (no)
EP (1) EP0667859B1 (no)
JP (1) JP3542597B2 (no)
KR (1) KR100295545B1 (no)
AT (1) ATE195730T1 (no)
AU (1) AU676863B2 (no)
CA (1) CA2148595C (no)
DE (1) DE69329293T2 (no)
DK (1) DK0667859T3 (no)
ES (1) ES2150950T3 (no)
FI (1) FI113044B (no)
GB (1) GB9223168D0 (no)
GR (1) GR3034883T3 (no)
HK (1) HK1013420A1 (no)
HU (1) HU226459B1 (no)
NO (1) NO305364B1 (no)
NZ (1) NZ257376A (no)
PT (1) PT667859E (no)
WO (1) WO1994010149A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
TW541184B (en) 1997-04-30 2003-07-11 Univ Leland Stanford Junior Use of annexin for imaging cell death in vivo
US6403054B1 (en) * 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6844333B1 (en) * 1999-03-26 2005-01-18 The Trustees Of The University Of Pennsylvania Method of treating atherosclerosis
CA2723664A1 (en) * 2000-03-22 2001-09-27 Solulink, Incorporated Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US7102024B1 (en) 2000-08-01 2006-09-05 Schwartz David A Functional biopolymer modification reagents and uses thereof
US6686461B1 (en) * 2000-03-22 2004-02-03 Solulink Bioscience, Inc. Triphosphate oligonucleotide modification reagents and uses thereof
WO2002080754A2 (en) 2001-04-03 2002-10-17 Theseus Imaging Corporation Methods for using annexin for detecting cell death in vivo and treating associated conditions
JP2004529922A (ja) 2001-04-03 2004-09-30 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 生体内における細胞死の画像化の方法
GB0130845D0 (en) * 2001-12-22 2002-02-06 James Peter Analysis
US7158353B2 (en) * 2003-11-06 2007-01-02 Seagate Technology Llc Magnetoresistive sensor having specular sidewall layers
EP1807092B1 (en) 2004-11-05 2016-09-07 The Children's Hospital of Philadelphia Biodegradable linkers for molecular therapies
EP2942351B1 (en) * 2011-01-31 2016-10-12 ETH Zurich Trifunctional crosslinking reagents
CA2838158C (en) 2011-06-03 2019-07-16 3M Innovative Properties Company Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
EP3153180A1 (en) 2011-06-03 2017-04-12 3M Innovative Properties Company Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use

Also Published As

Publication number Publication date
FI952141A0 (fi) 1995-05-04
HU226459B1 (en) 2008-12-29
WO1994010149A1 (en) 1994-05-11
DE69329293T2 (de) 2000-12-28
HUT72332A (en) 1996-04-29
AU676863B2 (en) 1997-03-27
CA2148595C (en) 2002-05-21
NO951751L (no) 1995-06-12
EP0667859B1 (en) 2000-08-23
JP3542597B2 (ja) 2004-07-14
EP0667859A1 (en) 1995-08-23
JPH08502744A (ja) 1996-03-26
ATE195730T1 (de) 2000-09-15
NO305364B1 (no) 1999-05-18
HK1013420A1 (en) 1999-08-27
AU5375594A (en) 1994-05-24
PT667859E (pt) 2001-02-28
KR100295545B1 (ko) 2001-09-17
KR950704256A (ko) 1995-11-17
DE69329293D1 (de) 2000-09-28
DK0667859T3 (da) 2000-10-16
CA2148595A1 (en) 1994-05-11
US5679778A (en) 1997-10-21
FI952141A (fi) 1995-05-04
GR3034883T3 (en) 2001-02-28
FI113044B (fi) 2004-02-27
GB9223168D0 (en) 1992-12-16
NZ257376A (en) 1996-02-27
ES2150950T3 (es) 2000-12-16

Similar Documents

Publication Publication Date Title
NO951751D0 (no) Molekylmerking ved bruk av 2-hydraminopyridin-derivater
NO20031490L (no) Alifatisk nitrogenholdig 5-kantet ring-forbindelse
FR2663845B1 (fr) Composition cosmetique reductrice pour permanente contenant un derive d'acide n-(mercapto alkyl) succinamique ou de n-(mercapto alkyl) succinimide, et son utilisation dans un procede de deformation permanente des cheveux.
NO20003133D0 (no) Anilidderivater, fremstilling og anvendelse derav
DE68923274D1 (de) Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins.
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
KR830010072A (ko) 아미디노 피페리딘 유도체의 제조방법
KR910000751A (ko) 세펨 화합물 및 이의 제조방법
SE8505716D0 (sv) Novel compounds and conjugates thereof
DE69819727D1 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
DK0548338T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter
ES2104682T3 (es) Fluor-compuestos.
CA2211385A1 (en) N-1-carboxyalkyl derivatives of lsd
RU2219161C2 (ru) Способ синтеза таксанов
DE50004382D1 (de) Verfahren zur Herstellung von Guanidinderivaten
ES2098338T3 (es) Heteroarilmetilbencenos.
KR850007067A (ko) 옥스아자포스포린 유도체의 염의 제조방법
BR9610804A (pt) Processo para preparar um composto composto e sal dissódico
ES2099963T3 (es) Sintesis de indoles mediante deshidrogenacion de indolinas.
KR920004377A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약제학적 조성물
KR960022482A (ko) 트리아졸화합물의 제조방법
KR940014350A (ko) 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법
TH16053A (no)
KR960703109A (ko) N-보호된 N-알킬 아미노산의 제조 방법(Process for Producing N-Protected N-Alkylated Amino Acids)
KR930019621A (ko) 신규 n-(2-할로알카노일옥시)석신이미드 유도체 및 그 제조방법

Legal Events

Date Code Title Description
MK1K Patent expired